• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. FIBEROPTIX ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-05840-LWS
Device Problems Fluid/Blood Leak (1250); Material Rupture (1546)
Patient Problem Chest Pain (1776)
Event Date 04/09/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the intra-aortic balloon (iab) was inserted and the patient was transferred from one hospital to another and upon arrival, large amount of blood was noted in tubing.Unknown if alarms occurred.The operation was ceased and tubing was clamped.Patient began to experience pain in left arm.The balloon was removed and the patient was given nitroglycerine.No new balloon inserted.Patient underwent cardiac surgery for underlying disease and is stable.Patient outcome reported as stable.There is no report of patient death or serious injury.
 
Event Description
It was reported that the intra-aortic balloon (iab) was inserted and the patient was transferred from one hospital to another and upon arrival, large amount of blood was noted in tubing.Unknown if alarms occurred.The operation was ceased and tubing was clamped.Patient began to experience pain in left arm.The balloon was removed and the patient was given nitroglycerine.No new balloon inserted.Patient underwent cardiac surgery for underlying disease and is stable.Patient outcome reported as stable.There is no report of patient death or serious injury.
 
Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint of blood in helium pathway is confirmed.A puncture to the bladder, consistent with contact from the broken fiber, was found near the distal tip of the iab which allowed blood to enter the helium pathway.The root cause of the broken fiber is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.A nonconformance has been initiated to further investigate the root cause.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FIBEROPTIX ULTRA 8 IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key7491493
MDR Text Key107565315
Report Number3010532612-2018-00125
Device Sequence Number1
Product Code DSP
Combination Product (y/n)N
PMA/PMN Number
K021462
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 04/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Catalogue NumberIAB-05840-LWS
Device Lot Number18F17K0005
Other Device ID Number00801902007247
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/27/2018
Date Manufacturer Received06/12/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NITROGLYCERINE; NITROGLYCERINE
-
-